Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2001

View Archived Issues

NIH licensing opportunity: detection and quantification of CR1 in human milk using ELISA

NIH licensing opportunity: identification of new small bacterial RNAs

Durect acquires Southern BioSystems

Rituximab filed in E.U., approved in U.S. for expanded indications

FDA advisory committee to review NDA for first-in-class antidiabetic therapy

First combination hepatitis A & B vaccine approved by FDA

Centaur's CPI-1189 shows efficacy in phase IIa trials in patients with dementia

Crucell and UMC Utrecht enter alliance for type 2 diabetes therapeutics

Phase II liver cancer trial of Zadaxin/TACE announced

Manzamine alkaloids from deep-sea sponge show potent antiinfective activity

Anticonvulsant agents reduce trigeminal nerve-induced neurovascular reflexes

Progenics reacquires rights to cancer vaccines; phase III trial in melanoma begins

First-quarter 2001 highlights and product update presented by NPS

AltaRex presents encouraging results from phase I BrevaRex MAb trial

Long-term safety and efficacy of adalimumab demonstrated in active RA

Company Profile: Hormos Medical

NDA filed in Hong Kong for NexMed's ED treatment

Humanized antibody safe and effective in phase I/II studies in RA patients

Several ARVO presentations cover preclinical and early clinical profile of AL-6598

AGI Dermatics reports promising results with skin cancer prevention drug

Company Profile: OPi

Cor patents new series of factor Xa inhibitors with high potency and selectivity

New indole-based sPLA2 inhibitors in development at Lilly

AstraZeneca identifies quinazoline derivatives as inhibitors of aurora2 kinase

Preparation and use of calcium channel antagonist series described by Ortho-McNeil

Small molecules from Genentech inhibit interaction between alpha4 integrins and their ligands

Meiji Seika's new phosphonic acid derivatives particularly useful in thrombotic disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...